Genaris Overview

  • Founded

  • 2002

Founded
  • Status

  • Out of Business

  • Employees

  • 18

Employees
  • Latest Deal Type

  • Out of Business

Genaris General Information

Description

Provider of technologies for chemical production industries. The company offers a bio-upcycling system that are used for the identification of gene structures, prediction of gene product functions and prediction of gene expression levels by the manufacturer of chemical products. It also offers various information technology services for medicine, agriculture and food production industries.

Contact Information

Website
www.genaris.co.jp
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Systems and Information Management
Other Industries
Database Software
Primary Office
  • Kanagawa Prefecture Tsurumi-ku, Yokohama City
  • Ono-cho, 75-1 leading venture Plaza 2-308
  • Yokohama, 230-0046
  • Japan
+81 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genaris Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Nov-2016 Completed Out of Business
1. Early Stage VC Completed Startup
To view Genaris’s complete valuation and funding history, request access »

Genaris Patents

  • 4

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Genaris Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-5678356-B2 Method for producing phenolic acid Active 11-Aug-2011 00000000
JP-WO2013021503-A1 Method for producing phenolic acid Granted 11-Aug-2011 00000000
JP-5866604-B2 Novel microorganism and method for producing 2,3-dihydroxybenzoic acid and salicylic acid using the same Active 14-Dec-2010 000000000
JP-WO2012081084-A1 Novel microorganism and method for producing 2,3-dihydroxybenzoic acid and salicylic acid using the same Granted 14-Dec-2010 C12N15/52

Genaris Executive Team (1)

Name Title Board Seat Contact Info
Tatsunari Nishi Ph.D Chief Executive Officer, President & Founder
To view Genaris’s complete executive team members history, request access »

Genaris Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial